| Primary |
| Sepsis |
57.6% |
| Septic Shock |
17.5% |
| Multi-organ Failure |
5.1% |
| Pneumonia |
3.9% |
| Sedation |
2.1% |
| Shock |
1.8% |
| Abdominal Sepsis |
1.5% |
| Prophylaxis |
1.5% |
| Urosepsis |
1.3% |
| Antibiotic Therapy |
1.0% |
| Thrombosis Prophylaxis |
0.9% |
| Infection |
0.8% |
| Hypotension |
0.8% |
| Meningococcal Sepsis |
0.8% |
| Autoimmune Hepatitis |
0.7% |
| Supplementation Therapy |
0.7% |
| Anticoagulant Therapy |
0.6% |
| Mechanical Ventilation |
0.6% |
| Blood Antidiuretic Hormone |
0.5% |
| Multiple Myeloma |
0.5% |
|
| Death |
20.6% |
| Thrombocytopenia |
15.4% |
| Platelet Count Decreased |
10.2% |
| Sepsis |
9.3% |
| Septic Shock |
6.5% |
| Multi-organ Failure |
5.5% |
| Haemorrhage |
4.8% |
| Cardiac Arrest |
3.3% |
| International Normalised Ratio Increased |
3.2% |
| Respiratory Failure |
3.2% |
| Haemorrhage Intracranial |
3.0% |
| Hypotension |
2.9% |
| Subarachnoid Haemorrhage |
1.9% |
| Gastrointestinal Haemorrhage |
1.8% |
| Pulmonary Haemorrhage |
1.6% |
| Cerebral Haemorrhage |
1.5% |
| General Physical Health Deterioration |
1.5% |
| Pneumonia |
1.5% |
| Wound Haemorrhage |
1.3% |
| Pulmonary Embolism |
1.1% |
|
| Secondary |
| Sepsis |
26.6% |
| Septic Shock |
9.4% |
| Drug Use For Unknown Indication |
7.8% |
| Sedation |
7.0% |
| Abdominal Sepsis |
6.3% |
| Shock |
6.3% |
| Thrombosis Prophylaxis |
6.3% |
| Product Used For Unknown Indication |
5.5% |
| Haemodynamic Instability |
3.1% |
| Pneumonia |
3.1% |
| Staphylococcal Sepsis |
3.1% |
| Ill-defined Disorder |
2.3% |
| Multi-organ Failure |
2.3% |
| Antibiotic Therapy |
1.6% |
| Blood Pressure Decreased |
1.6% |
| Endotracheal Intubation |
1.6% |
| Infection |
1.6% |
| Prophylaxis |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Renal Transplant |
1.6% |
|
| Multi-organ Failure |
16.2% |
| Sepsis |
10.8% |
| Death |
9.5% |
| Platelet Count Decreased |
8.1% |
| Thrombocytopenia |
6.8% |
| Tracheal Haemorrhage |
6.8% |
| International Normalised Ratio Increased |
5.4% |
| Ventricular Arrhythmia |
5.4% |
| Pneumonia |
4.1% |
| Troponin Increased |
4.1% |
| Haemorrhage |
2.7% |
| Medication Error |
2.7% |
| Restlessness |
2.7% |
| Septic Shock |
2.7% |
| Therapy Non-responder |
2.7% |
| Urinary Bladder Haemorrhage |
2.7% |
| Wound Haemorrhage |
2.7% |
| Clostridium Difficile Colitis |
1.4% |
| Drug Ineffective |
1.4% |
| General Physical Health Deterioration |
1.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
37.6% |
| Sepsis |
10.6% |
| Product Used For Unknown Indication |
9.9% |
| Septic Shock |
7.8% |
| Pneumonia |
5.0% |
| Systemic Candida |
3.5% |
| Depression |
2.8% |
| Escherichia Bacteraemia |
2.8% |
| Haemodynamic Instability |
2.8% |
| Hypotension |
2.8% |
| Staphylococcal Infection |
2.8% |
| Bacteraemia |
1.4% |
| Convulsion |
1.4% |
| Deep Vein Thrombosis |
1.4% |
| Endocarditis Staphylococcal |
1.4% |
| Pain |
1.4% |
| Preoperative Care |
1.4% |
| Systemic Lupus Erythematosus |
1.4% |
| Anaemia |
0.7% |
| Anticoagulant Therapy |
0.7% |
|
| Septic Shock |
18.2% |
| Cytolytic Hepatitis |
12.1% |
| Vasculitis |
9.1% |
| Hypoglycaemia |
6.1% |
| Pyrexia |
6.1% |
| Toxic Epidermal Necrolysis |
6.1% |
| Anxiety |
3.0% |
| Breast Enlargement |
3.0% |
| Cardio-respiratory Arrest |
3.0% |
| Circulatory Collapse |
3.0% |
| Death |
3.0% |
| Disability |
3.0% |
| Drug Ineffective |
3.0% |
| Drug Level Decreased |
3.0% |
| Eosinophilic Pneumonia |
3.0% |
| Multi-organ Failure |
3.0% |
| Ototoxicity |
3.0% |
| Pneumonitis |
3.0% |
| Purpura |
3.0% |
| Rash Macular |
3.0% |
|
